...series A round led by BioMedinvest and Life Science Partners. Existing investors Grazia Equity and Mulligan BioCapital...

...raised: E15.1 million ($18.5 million) Investors: Global Life Science Ventures; BioMedinvest AG; FNI Venture Capital; Mulligan BioCapital...

...in a series A round led by Global Life Science Ventures and BioMedinvest. FNI and Mulligan BioCapital...

...round led by Global Life Sciences Ventures and Atlas Venture. Other investors included EMBL and Mulligan BioCapital...

...a partner on its life science team. zur Hausen previously was a managing director at Mulligan BioCapital...

...Christoph Schroder of JSB Partners will join Coley's board. Schroder sits on the board of Mulligan BioCapital...

...Funds raised: E29.7 million ($28.7 million) Investors: 3i, Bayern Kapital; BdW mbH; BioM AG; DVC; Mulligan BioCapital...

...diseases. Including this round, 4SC has raised about E30 million ($35 million). Investors included 3i; Mulligan Biocapital...

...million ($10.4 million) in a private round. Investors included 3i Group; Deutsche Venture Capital DVC; Mulligan Biocapital...

...by TVM Techno Venture Management. Other inventors included DVC Deutsche Venture Capital; IKB Private Equity; Mulligan BioCapital...